Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CNSP | US
0.02
19.67%
Healthcare
Biotechnology
30/06/2024
21/10/2024
0.15
0.12
0.15
0.12
CNS Pharmaceuticals Inc. a clinical pharmaceutical company engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals Inc. Reata Pharmaceuticals Inc. Pomeranian Medical University and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was incorporated in 2017 and is based in Houston Texas.
View LessStrength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Equity (< 0.25)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
118.3%1 month
96.6%3 months
166.8%6 months
174.0%-
-
4.57
-0.03
0.05
0.40
-
-
-15.98M
4.69M
4.69M
-
-
-
-
-1.02K
0.44
2.11
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.04
Range1M
0.04
Range3M
1.14
Rel. volume
4.53
Price X volume
869.54K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
XORTX Therapeutics Inc. Common Stock | XRTX | Biotechnology | 1.71 | 5.15M | -9.04% | n/a | 3.09% |
BIONOMICS LIMITED/FI | BNOX | Biotechnology | 0.2955 | 5.12M | -1.53% | n/a | 0.59% |
180 Life Sciences Corp | ATNF | Biotechnology | 4.97 | 5.10M | -1.19% | n/a | -105.81% |
Molecular Templates Inc | MTEM | Biotechnology | 0.75 | 4.94M | 0.00% | n/a | 155.07% |
QLGN | QLGN | Biotechnology | 0.1825 | 4.93M | 9.15% | n/a | -39.04% |
Enveric Biosciences Inc | ENVB | Biotechnology | 0.538 | 4.80M | 20.33% | n/a | 0.00% |
Azitra Inc | AZTR | Biotechnology | 0.61 | 4.65M | 0.00% | 0.01 | 41.86% |
ADTX | ADTX | Biotechnology | 1.09 | 4.60M | 3.81% | n/a | 122.46% |
Pasithea Therapeutics Corp. Common Stock | KTTA | Biotechnology | 4.39 | 4.59M | 1.62% | n/a | 0.00% |
Hepion Pharmaceuticals Inc | HEPA | Biotechnology | 0.7501 | 4.35M | -8.30% | n/a | 4.33% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.40 | 0.53 | Cheaper |
Ent. to Revenue | - | 3,967.00 | - |
PE Ratio | - | 41.03 | - |
Price to Book | 4.57 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 166.81 | 72.80 | Riskier |
Debt to Equity | -0.03 | -1.23 | Expensive |
Debt to Assets | 0.05 | 0.25 | Cheaper |
Market Cap | 4.69M | 3.66B | Emerging |